Use your antibodies-online credentials, if available.
抗Human XYLT2 抗体:
抗Mouse (Murine) XYLT2 抗体:
抗Rat (Rattus) XYLT2 抗体:
mutations in the XYLT2 gene result in a variable phenotype dominated by spinal osteoporosis, cataract, and hearing loss.
XYLT2 mutations cause a relatively distinct phenotype, the so-called spondyloocular syndrome.
Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.
Demonstrate that XT-II is the predominant isoenzyme responsible for XT activity in serum. The proof was performed using UDP-xylose as the xylose donor, as well as the compound UDP-4-azido-4-deoxyxylose, which is a selective xylose donor for XT-I.
Seven XYLT2 promoter single nucleotide variants (SNVs) were identified and genotyped.
The study identified and characterized for the first time the XYLT2 gene promoter region and transcription factors involved in its regulation.
xylotransferase genes might be potential candidate genes predisposing to diabetic nephropathy in type 1 diabetic patients
recombinant expression and cloning of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II
demonstrate that a soluble form of human XT-II expressed in the xylosyltransferase-deficient pgsA-745 (S745) Chinese hamster ovary cell line is indeed capable of catalyzing the transfer of xylose to a variety of peptide substrates
Our data show for the first time that XT-I and XT-II are xylosyltransferases with similar but not identical properties, pointing to their potential role in modulating the cellular proteoglycan pool.
These results point to skeletal growth and tissue remodeling as a cause of the high XT activity in children
Our data show that a XYLT2 haplotype is associated with nephropathy in type 1 diabetic patients
The deviation from Hardy-Weinberg equilibrium of two XYLT2 variants might be due to gene-phenotype associations which remain to be explored, as well as the possibility of gene-gene interactions.
A protein sequence alignment and polarity plot of XylT-I and XylT-II revealed several Cardin-Weintraub motifs and charged surface clusters, which might be involved in electrostatic-mediated heparin-binding.
serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis.
alterations in proteoglycans (PGs)concentrations can occur due to loss of XylT2, and that reduced PGs can induce cyst development
the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity.
The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis.
, xylosyltransferase 2
, peptide O-xylosyltransferase 2
, proteoglycan core protein beta-D-xylosyltransferase
, xylosyltransferase 2-like
, UDP-D-xylose:core protein beta-D-xylosyltransferase
, UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase
, peptide O-xylosyltransferase 1
, protein xylosyltransferase 2